China’s draft pharmaceutical trial rules aim to balance innovation with drug availability; CAC issues first rules to regulate facial recognition technology; and UBS becomes the 5th wholly foreign-owned securities firm in China.
April 03, 2025
Capital Markets
Hong Kong stock market rebounds when Chinese government halts Swiss listings; China backs AI with government investment fund; and China’s Supreme People’s Court further protects intellectual property rights in apple plant varieties.
March 14, 2025China clamps down on small-cap U.S. listings by Chinese issuers; China mandates personal information protection compliance audits for companies; and AI company loses against Reuters in U.S. summary judgment with key implication
March 07, 2025Trump signs memorandum to restrict investments that do not serve American interests; A Jiangsu court ruled that investments in overseas crypto projects are not protected under Chinese law; and Chinese companies raise funds in hope of easing of regulations against private enterprises
February 27, 2025CSRC clarifies on the shareholding changes in takeovers of listed companies. / CLP Reference: 3700/25.01.10 ; Issued: 2025-01-10 ; Effective: 2025-01-10
February 26, 2025U.S. attempts to exclude Chinese access to AI chips by designating ‘gatekeeper’ companies; Shein’s UK IPO application scrutinized over forced labor concerns; and China’s AI Standards Committee to include executives from tech giants
December 18, 2024Chinese developer sues Apple for removing its app from the App Store; CSRC requires increased shareholder returns to boost stock prices; and Foreigners are choosing to work remotely instead of moving to China
November 21, 2024The final rules of reverse CFIUS differ from the draft version; China changes its foreign investment rules to attract more long-term and high-quality investments; and Chinese data center company raises $1 billion from U.S. PE investors.
November 07, 2024Pilot project allows Tesla and HSBC to independently operate data centers in China; WeRide's lead legal adviser comments on overseas IPOs; and Austria's Starlinger settles patent infringement case with Chinese machine manufacturers.
October 31, 2024Bayer successfully files for the first cross-border data transfer in Beijing Free Trade Zone; Yuanbao plans to list on Nasdaq after some Chinese IPO successes, but setbacks also exist; and China's environmental regulator merges approval procedures to encourage private business
September 26, 2024
